Announced

Concentra Biosciences to acquire CARGO Therapeutics for $217.5m.

Synopsis

Concentra Biosciences, a provider of clinical and business development services, offered to acquire CARGO Therapeutics, a clinical-stage biotechnology company, for $217.5m. Following a strategic review process conducted with the assistance of CARGO’s management and legal and financial advisors and other factors considered, the CARGO board of directors has unanimously determined that the acquisition by Concentra is in the best interests of all CARGO stockholders and has approved the Merger Agreement and related transactions.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite